ProCE Banner Activity


ASH: Key News in Hematologic Malignancies

Conference Coverage
Text Module

The 63rd American Society of Hematology (ASH) Annual Meeting and Exposition, held from December 11-14, 2021 in Atlanta, Georgia, is the world’s premier event in hematology—both malignant and nonmalignant. Even though the ASH Annual Meeting regularly features important studies that are crucial for improving patient care, keeping up with all the advances—and knowing how and when to apply them to the management of patients—can be challenging. This conference coverage activity features audio soundbites highlighting late-breaking and important new and promising datasets presented at ASH 2021 in acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia/lymphoma, and indolent and aggressive B-cell non-Hodgkin lymphomas. In this activity, Sandra Kurtin, PhD, ANP-C, AOCN provides expert perspectives and insights into the clinical application and implication of selected scientific abstracts and how the data may impact patient care.

Physician Assistants: maximum of 1.00 hours of AAPA Category 1 CME credits Registered Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit

Released: March 31, 2022

Expiration: March 30, 2023

No longer available for credit.



Sandra Kurtin

Sandra Kurtin, PhD, ANP-C, AOCN

Clinical Assistant Professor
Department of Medicine
The University of Arizona
Tucson, Arizona


This activity is supported by an educational grant from Amgen.

Provided by

ProCE Banner



Target Audience

Oncology NPs, PAs, and nurses

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify recent practice-changing data and novel therapeutic approaches for hematologic malignancies

  • Describe strategies for identification and management of adverse events associated with novel therapies hematologic malignancies


All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Kurtin: consultant/advisor/speaker: Amgen, AstraZeneca, Bristol-Myers Squibb, Epizyme, Incyte, Sanofi, Pharmacyclics.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. Review the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

The estimated time to complete this activity is 1.00 hour.

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.

Release date: March 31, 2022
Expiration date: March 30, 2023


Conference Coverage


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.



Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until March 30, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Jessica Garner, DMSc, PA-C, University of the Pacific, Sacramento, California

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.